Back to search

Article

Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS Study

2022-03-01

Abstract excerpt

Background: Several cases of unusual thrombotic events and thrombocytopenia have occurred after vaccination with recombinant adenoviral vectors encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to elucidate the impact of a COVID-19 heterologous vaccination schedule including priming with an adenovirus vaccine on haemostasis and coagulation profile.<br><br>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
31fe7187-dcc8-5a41-a51b-82a89d3b4f9c
DOI
10.2139/ssrn.4046663
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS StudyDOI 10.2139/ssrn.4046663
Select a neighboring publication to make it the new centre.